Table: Santen Pharm -2019/20 parent results

SANTEN PHARMACEUTICAL

08/05/2020 07:00

May 8 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            182.61          176.21                                
                 (+3.6 pct)      (+2.5 pct)                              
  Operating         34.43           32.85                                
                 (+4.8 pct)      (+5.0 pct)                              
  Recurring         34.86           33.19                                
                 (+5.0 pct)      (+4.7 pct)                              
  Net               27.40           28.01                                
                 (-2.2 pct)      (+10.1 pct)                             
  EPS             68.63 yen       68.96 yen                              
  EPS Diluted     68.46 yen       68.76 yen                              
  Ann Div         27.00 yen       26.00 yen      28.00 yen               
  -Q2 Div         13.00 yen       13.00 yen      14.00 yen               
  -Q4 Div         14.00 yen       13.00 yen      14.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T